Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-((S)-2-(5-azido-2-nitrobenzamido)hexanamido)-5-sec-butyl-1-((S)-2-((S)-1-carboxy-2-phenylethylcarbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid
ID: ALA3275932
Chembl Id: CHEMBL3275932
PubChem CID: 90679289
Max Phase: Preclinical
Molecular Formula: C63H84N18O16
Molecular Weight: 1349.47
Molecule Type: Small molecule
Associated Items: